Artisan Partners Limited Partnership Y M Abs Therapeutics, Inc. Transaction History

Artisan Partners Limited Partnership

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$6.55 - $17.42 $10.4 Million - $27.6 Million	-1,581,845 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$15.51 - $29.31 $1.66 Million - $3.13 Million	-106,711 Reduced 6.32%	1,581,845 $25.6 Million
Q3 2021 Nov 12, 2021	BUY	$27.47 - $37.31 $10.2 Million - $13.8 Million	370,277 Added 28.09%	1,688,556 $48.2 Million
Q2 2021 Aug 12, 2021	BUY	$25.45 - $37.64 $9,645 - $14,265	379 Added 0.03%	1,318,279 $44.6 Million
Q1 2021 May 11, 2021	BUY	$29.16 - $51.96 $7.89 Million - $14.1 Million	270,484 Added 25.82%	1,317,900 $39.9 Million
Q4 2020 Feb 10, 2021	BUY	$37.86 - $54.26 $12.2 Million - $17.5 Million	321,788 Added 44.35%	1,047,416 $51.9 Million
Q3 2020 Nov 12, 2020	BUY	$35.13 - $43.62 $3.49 Million - $4.33 Million	99,362 Added 15.87%	725,628 $27.9 Million
Q2 2020 Aug 12, 2020	BUY	$23.66 - $49.53 $1.88 Million - $3.94 Million	79,626 Added 14.57%	626,266 $27.1 Million
Q1 2020 May 12, 2020	BUY	$14.39 - $35.8 $7.87 Million - $19.6 Million	546,640 New	546,640 $14.3 Million

106

24.5M

40.3K

400

Ticker YMAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,719,500
Market Cap $487M
Description
Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...

Get notified when there are updates to the investment portfolio of Artisan Partners Limited Partnership, based on Form 13F filings with the SEC.

Stay updated on Artisan Partners Limited Partnership with notifications on news.